Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50
HLGN.WS
HLGN.WS was delisted on the 7th of November, 2023.
17 hedge funds and large institutions have $2.41M invested in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 17 → 17 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
6% less capital invested
Capital invested by funds: $2.56M → $2.41M (-$154K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$40.5K |
| 2 |
ACM
Atalaya Capital Management
New York
|
+$12.6K |
| 3 |
CCP
Corbin Capital Partners
New York
|
+$6.51K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
-$76.7K |
| 2 |
HF
HRT Financial
New York
|
-$5K |
| 3 |
Jane Street
New York
|
-$85 |
HLGN.WS Hedge Fund Activity: Q3 2022 in Review
17 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) for Q3 2022, worth a combined $2.41M — down 6% from $2.56M a quarter earlier.
Fund positioning in HLGN.WS was balanced in Q3 2022: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was LMR Partners, adding an estimated $40.5K. The largest seller was Privium Fund Management, cutting an estimated $76.7K.
- 17 institutional investors held Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $2.41M of Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 stock for Q3 2022, down 6% quarter-over-quarter.
- 1 fund opened new Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 positions in Q3 2022 and 1 closed out, a net change of 0 holders.
- The largest Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 buyer in Q3 2022 was LMR Partners, an estimated $40.5K added.
- The largest Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 seller in Q3 2022 was Privium Fund Management, an estimated $76.7K sold.
Based on aggregated 13F filings for Q3 2022.